Global Pertussis Booster Vaccine Market Growth 2026-2032
The global Pertussis Booster Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Pertussis booster vaccine is a vaccine that protects against whooping cough (pertussis). There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71?85% effective.
United States market for Pertussis Booster Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Pertussis Booster Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Pertussis Booster Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Pertussis Booster Vaccine players cover Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Pertussis Booster Vaccine Industry Forecast? looks at past sales and reviews total world Pertussis Booster Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Pertussis Booster Vaccine sales for 2026 through 2032. With Pertussis Booster Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pertussis Booster Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Pertussis Booster Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pertussis Booster Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pertussis Booster Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pertussis Booster Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pertussis Booster Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Pertussis Booster Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Pertussis Booster Vaccine market?
What factors are driving Pertussis Booster Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pertussis Booster Vaccine market opportunities vary by end market size?
How does Pertussis Booster Vaccine break out by Type, by Application?
Pertussis booster vaccine is a vaccine that protects against whooping cough (pertussis). There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71?85% effective.
United States market for Pertussis Booster Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Pertussis Booster Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Pertussis Booster Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Pertussis Booster Vaccine players cover Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Pertussis Booster Vaccine Industry Forecast? looks at past sales and reviews total world Pertussis Booster Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Pertussis Booster Vaccine sales for 2026 through 2032. With Pertussis Booster Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pertussis Booster Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Pertussis Booster Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pertussis Booster Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pertussis Booster Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pertussis Booster Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pertussis Booster Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Pertussis Booster Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Acellular Vaccines
- Whole-Cell Vaccines
- 12 Months Below
- 12 Months Above
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi Pasteur
- GSK
- Mitsubishi Tanabe Pharma
- KM Biologics
- Wuhan Institute of Biological Products
- Walvax Biotechnology
- Chengdu Institute of Biological Products
- Minhai Biotechnology
What is the 10-year outlook for the global Pertussis Booster Vaccine market?
What factors are driving Pertussis Booster Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pertussis Booster Vaccine market opportunities vary by end market size?
How does Pertussis Booster Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pertussis Booster Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pertussis Booster Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pertussis Booster Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Pertussis Booster Vaccine Segment by Type
2.2.1 Acellular Vaccines
2.2.2 Whole-Cell Vaccines
2.2.3 Pertussis Booster Vaccine Sales by Type
2.2.3.1 Global Pertussis Booster Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Pertussis Booster Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Pertussis Booster Vaccine Sale Price by Type (2021-2026)
2.3 Pertussis Booster Vaccine Segment by Application
2.3.1 12 Months Below
2.3.2 12 Months Above
2.3.3 Pertussis Booster Vaccine Sales by Application
2.3.3.1 Global Pertussis Booster Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Pertussis Booster Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Pertussis Booster Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Pertussis Booster Vaccine Breakdown Data by Company
3.1.1 Global Pertussis Booster Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Pertussis Booster Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Pertussis Booster Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Pertussis Booster Vaccine Revenue by Company (2021-2026)
3.2.2 Global Pertussis Booster Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Pertussis Booster Vaccine Sale Price by Company
3.4 Key Manufacturers Pertussis Booster Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pertussis Booster Vaccine Product Location Distribution
3.4.2 Players Pertussis Booster Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PERTUSSIS BOOSTER VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Pertussis Booster Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Pertussis Booster Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pertussis Booster Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pertussis Booster Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Pertussis Booster Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pertussis Booster Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pertussis Booster Vaccine Sales Growth
4.4 APAC Pertussis Booster Vaccine Sales Growth
4.5 Europe Pertussis Booster Vaccine Sales Growth
4.6 Middle East & Africa Pertussis Booster Vaccine Sales Growth
5 AMERICAS
5.1 Americas Pertussis Booster Vaccine Sales by Country
5.1.1 Americas Pertussis Booster Vaccine Sales by Country (2021-2026)
5.1.2 Americas Pertussis Booster Vaccine Revenue by Country (2021-2026)
5.2 Americas Pertussis Booster Vaccine Sales by Type (2021-2026)
5.3 Americas Pertussis Booster Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pertussis Booster Vaccine Sales by Region
6.1.1 APAC Pertussis Booster Vaccine Sales by Region (2021-2026)
6.1.2 APAC Pertussis Booster Vaccine Revenue by Region (2021-2026)
6.2 APAC Pertussis Booster Vaccine Sales by Type (2021-2026)
6.3 APAC Pertussis Booster Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pertussis Booster Vaccine by Country
7.1.1 Europe Pertussis Booster Vaccine Sales by Country (2021-2026)
7.1.2 Europe Pertussis Booster Vaccine Revenue by Country (2021-2026)
7.2 Europe Pertussis Booster Vaccine Sales by Type (2021-2026)
7.3 Europe Pertussis Booster Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pertussis Booster Vaccine by Country
8.1.1 Middle East & Africa Pertussis Booster Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pertussis Booster Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Pertussis Booster Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Pertussis Booster Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pertussis Booster Vaccine
10.3 Manufacturing Process Analysis of Pertussis Booster Vaccine
10.4 Industry Chain Structure of Pertussis Booster Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pertussis Booster Vaccine Distributors
11.3 Pertussis Booster Vaccine Customer
12 WORLD FORECAST REVIEW FOR PERTUSSIS BOOSTER VACCINE BY GEOGRAPHIC REGION
12.1 Global Pertussis Booster Vaccine Market Size Forecast by Region
12.1.1 Global Pertussis Booster Vaccine Forecast by Region (2027-2032)
12.1.2 Global Pertussis Booster Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pertussis Booster Vaccine Forecast by Type (2027-2032)
12.7 Global Pertussis Booster Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi Pasteur
13.1.1 Sanofi Pasteur Company Information
13.1.2 Sanofi Pasteur Pertussis Booster Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Pasteur Pertussis Booster Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Pasteur Main Business Overview
13.1.5 Sanofi Pasteur Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Pertussis Booster Vaccine Product Portfolios and Specifications
13.2.3 GSK Pertussis Booster Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Mitsubishi Tanabe Pharma
13.3.1 Mitsubishi Tanabe Pharma Company Information
13.3.2 Mitsubishi Tanabe Pharma Pertussis Booster Vaccine Product Portfolios and Specifications
13.3.3 Mitsubishi Tanabe Pharma Pertussis Booster Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Mitsubishi Tanabe Pharma Main Business Overview
13.3.5 Mitsubishi Tanabe Pharma Latest Developments
13.4 KM Biologics
13.4.1 KM Biologics Company Information
13.4.2 KM Biologics Pertussis Booster Vaccine Product Portfolios and Specifications
13.4.3 KM Biologics Pertussis Booster Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 KM Biologics Main Business Overview
13.4.5 KM Biologics Latest Developments
13.5 Wuhan Institute of Biological Products
13.5.1 Wuhan Institute of Biological Products Company Information
13.5.2 Wuhan Institute of Biological Products Pertussis Booster Vaccine Product Portfolios and Specifications
13.5.3 Wuhan Institute of Biological Products Pertussis Booster Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Wuhan Institute of Biological Products Main Business Overview
13.5.5 Wuhan Institute of Biological Products Latest Developments
13.6 Walvax Biotechnology
13.6.1 Walvax Biotechnology Company Information
13.6.2 Walvax Biotechnology Pertussis Booster Vaccine Product Portfolios and Specifications
13.6.3 Walvax Biotechnology Pertussis Booster Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Walvax Biotechnology Main Business Overview
13.6.5 Walvax Biotechnology Latest Developments
13.7 Chengdu Institute of Biological Products
13.7.1 Chengdu Institute of Biological Products Company Information
13.7.2 Chengdu Institute of Biological Products Pertussis Booster Vaccine Product Portfolios and Specifications
13.7.3 Chengdu Institute of Biological Products Pertussis Booster Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Chengdu Institute of Biological Products Main Business Overview
13.7.5 Chengdu Institute of Biological Products Latest Developments
13.8 Minhai Biotechnology
13.8.1 Minhai Biotechnology Company Information
13.8.2 Minhai Biotechnology Pertussis Booster Vaccine Product Portfolios and Specifications
13.8.3 Minhai Biotechnology Pertussis Booster Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Minhai Biotechnology Main Business Overview
13.8.5 Minhai Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pertussis Booster Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pertussis Booster Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pertussis Booster Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Pertussis Booster Vaccine Segment by Type
2.2.1 Acellular Vaccines
2.2.2 Whole-Cell Vaccines
2.2.3 Pertussis Booster Vaccine Sales by Type
2.2.3.1 Global Pertussis Booster Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Pertussis Booster Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Pertussis Booster Vaccine Sale Price by Type (2021-2026)
2.3 Pertussis Booster Vaccine Segment by Application
2.3.1 12 Months Below
2.3.2 12 Months Above
2.3.3 Pertussis Booster Vaccine Sales by Application
2.3.3.1 Global Pertussis Booster Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Pertussis Booster Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Pertussis Booster Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Pertussis Booster Vaccine Breakdown Data by Company
3.1.1 Global Pertussis Booster Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Pertussis Booster Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Pertussis Booster Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Pertussis Booster Vaccine Revenue by Company (2021-2026)
3.2.2 Global Pertussis Booster Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Pertussis Booster Vaccine Sale Price by Company
3.4 Key Manufacturers Pertussis Booster Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pertussis Booster Vaccine Product Location Distribution
3.4.2 Players Pertussis Booster Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PERTUSSIS BOOSTER VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Pertussis Booster Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Pertussis Booster Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pertussis Booster Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pertussis Booster Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Pertussis Booster Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pertussis Booster Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pertussis Booster Vaccine Sales Growth
4.4 APAC Pertussis Booster Vaccine Sales Growth
4.5 Europe Pertussis Booster Vaccine Sales Growth
4.6 Middle East & Africa Pertussis Booster Vaccine Sales Growth
5 AMERICAS
5.1 Americas Pertussis Booster Vaccine Sales by Country
5.1.1 Americas Pertussis Booster Vaccine Sales by Country (2021-2026)
5.1.2 Americas Pertussis Booster Vaccine Revenue by Country (2021-2026)
5.2 Americas Pertussis Booster Vaccine Sales by Type (2021-2026)
5.3 Americas Pertussis Booster Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pertussis Booster Vaccine Sales by Region
6.1.1 APAC Pertussis Booster Vaccine Sales by Region (2021-2026)
6.1.2 APAC Pertussis Booster Vaccine Revenue by Region (2021-2026)
6.2 APAC Pertussis Booster Vaccine Sales by Type (2021-2026)
6.3 APAC Pertussis Booster Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pertussis Booster Vaccine by Country
7.1.1 Europe Pertussis Booster Vaccine Sales by Country (2021-2026)
7.1.2 Europe Pertussis Booster Vaccine Revenue by Country (2021-2026)
7.2 Europe Pertussis Booster Vaccine Sales by Type (2021-2026)
7.3 Europe Pertussis Booster Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pertussis Booster Vaccine by Country
8.1.1 Middle East & Africa Pertussis Booster Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pertussis Booster Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Pertussis Booster Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Pertussis Booster Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pertussis Booster Vaccine
10.3 Manufacturing Process Analysis of Pertussis Booster Vaccine
10.4 Industry Chain Structure of Pertussis Booster Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pertussis Booster Vaccine Distributors
11.3 Pertussis Booster Vaccine Customer
12 WORLD FORECAST REVIEW FOR PERTUSSIS BOOSTER VACCINE BY GEOGRAPHIC REGION
12.1 Global Pertussis Booster Vaccine Market Size Forecast by Region
12.1.1 Global Pertussis Booster Vaccine Forecast by Region (2027-2032)
12.1.2 Global Pertussis Booster Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pertussis Booster Vaccine Forecast by Type (2027-2032)
12.7 Global Pertussis Booster Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi Pasteur
13.1.1 Sanofi Pasteur Company Information
13.1.2 Sanofi Pasteur Pertussis Booster Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Pasteur Pertussis Booster Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Pasteur Main Business Overview
13.1.5 Sanofi Pasteur Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Pertussis Booster Vaccine Product Portfolios and Specifications
13.2.3 GSK Pertussis Booster Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Mitsubishi Tanabe Pharma
13.3.1 Mitsubishi Tanabe Pharma Company Information
13.3.2 Mitsubishi Tanabe Pharma Pertussis Booster Vaccine Product Portfolios and Specifications
13.3.3 Mitsubishi Tanabe Pharma Pertussis Booster Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Mitsubishi Tanabe Pharma Main Business Overview
13.3.5 Mitsubishi Tanabe Pharma Latest Developments
13.4 KM Biologics
13.4.1 KM Biologics Company Information
13.4.2 KM Biologics Pertussis Booster Vaccine Product Portfolios and Specifications
13.4.3 KM Biologics Pertussis Booster Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 KM Biologics Main Business Overview
13.4.5 KM Biologics Latest Developments
13.5 Wuhan Institute of Biological Products
13.5.1 Wuhan Institute of Biological Products Company Information
13.5.2 Wuhan Institute of Biological Products Pertussis Booster Vaccine Product Portfolios and Specifications
13.5.3 Wuhan Institute of Biological Products Pertussis Booster Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Wuhan Institute of Biological Products Main Business Overview
13.5.5 Wuhan Institute of Biological Products Latest Developments
13.6 Walvax Biotechnology
13.6.1 Walvax Biotechnology Company Information
13.6.2 Walvax Biotechnology Pertussis Booster Vaccine Product Portfolios and Specifications
13.6.3 Walvax Biotechnology Pertussis Booster Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Walvax Biotechnology Main Business Overview
13.6.5 Walvax Biotechnology Latest Developments
13.7 Chengdu Institute of Biological Products
13.7.1 Chengdu Institute of Biological Products Company Information
13.7.2 Chengdu Institute of Biological Products Pertussis Booster Vaccine Product Portfolios and Specifications
13.7.3 Chengdu Institute of Biological Products Pertussis Booster Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Chengdu Institute of Biological Products Main Business Overview
13.7.5 Chengdu Institute of Biological Products Latest Developments
13.8 Minhai Biotechnology
13.8.1 Minhai Biotechnology Company Information
13.8.2 Minhai Biotechnology Pertussis Booster Vaccine Product Portfolios and Specifications
13.8.3 Minhai Biotechnology Pertussis Booster Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Minhai Biotechnology Main Business Overview
13.8.5 Minhai Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pertussis Booster Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pertussis Booster Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Acellular Vaccines
Table 4. Major Players of Whole-Cell Vaccines
Table 5. Global Pertussis Booster Vaccine Sales by Type (2021-2026) & (K Dose)
Table 6. Global Pertussis Booster Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Pertussis Booster Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Pertussis Booster Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Pertussis Booster Vaccine Sale Price by Type (2021-2026) & (US$/Dose)
Table 10. Global Pertussis Booster Vaccine Sale by Application (2021-2026) & (K Dose)
Table 11. Global Pertussis Booster Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Pertussis Booster Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Pertussis Booster Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Pertussis Booster Vaccine Sale Price by Application (2021-2026) & (US$/Dose)
Table 15. Global Pertussis Booster Vaccine Sales by Company (2021-2026) & (K Dose)
Table 16. Global Pertussis Booster Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Pertussis Booster Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Pertussis Booster Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Pertussis Booster Vaccine Sale Price by Company (2021-2026) & (US$/Dose)
Table 20. Key Manufacturers Pertussis Booster Vaccine Producing Area Distribution and Sales Area
Table 21. Players Pertussis Booster Vaccine Products Offered
Table 22. Pertussis Booster Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Pertussis Booster Vaccine Sales by Geographic Region (2021-2026) & (K Dose)
Table 26. Global Pertussis Booster Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Pertussis Booster Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Pertussis Booster Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Pertussis Booster Vaccine Sales by Country/Region (2021-2026) & (K Dose)
Table 30. Global Pertussis Booster Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Pertussis Booster Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Pertussis Booster Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Pertussis Booster Vaccine Sales by Country (2021-2026) & (K Dose)
Table 34. Americas Pertussis Booster Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Pertussis Booster Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Pertussis Booster Vaccine Sales by Type (2021-2026) & (K Dose)
Table 37. Americas Pertussis Booster Vaccine Sales by Application (2021-2026) & (K Dose)
Table 38. APAC Pertussis Booster Vaccine Sales by Region (2021-2026) & (K Dose)
Table 39. APAC Pertussis Booster Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Pertussis Booster Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Pertussis Booster Vaccine Sales by Type (2021-2026) & (K Dose)
Table 42. APAC Pertussis Booster Vaccine Sales by Application (2021-2026) & (K Dose)
Table 43. Europe Pertussis Booster Vaccine Sales by Country (2021-2026) & (K Dose)
Table 44. Europe Pertussis Booster Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Pertussis Booster Vaccine Sales by Type (2021-2026) & (K Dose)
Table 46. Europe Pertussis Booster Vaccine Sales by Application (2021-2026) & (K Dose)
Table 47. Middle East & Africa Pertussis Booster Vaccine Sales by Country (2021-2026) & (K Dose)
Table 48. Middle East & Africa Pertussis Booster Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Pertussis Booster Vaccine Sales by Type (2021-2026) & (K Dose)
Table 50. Middle East & Africa Pertussis Booster Vaccine Sales by Application (2021-2026) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of Pertussis Booster Vaccine
Table 52. Key Market Challenges & Risks of Pertussis Booster Vaccine
Table 53. Key Industry Trends of Pertussis Booster Vaccine
Table 54. Pertussis Booster Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Pertussis Booster Vaccine Distributors List
Table 57. Pertussis Booster Vaccine Customer List
Table 58. Global Pertussis Booster Vaccine Sales Forecast by Region (2027-2032) & (K Dose)
Table 59. Global Pertussis Booster Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Pertussis Booster Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 61. Americas Pertussis Booster Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Pertussis Booster Vaccine Sales Forecast by Region (2027-2032) & (K Dose)
Table 63. APAC Pertussis Booster Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Pertussis Booster Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 65. Europe Pertussis Booster Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Pertussis Booster Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 67. Middle East & Africa Pertussis Booster Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Pertussis Booster Vaccine Sales Forecast by Type (2027-2032) & (K Dose)
Table 69. Global Pertussis Booster Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Pertussis Booster Vaccine Sales Forecast by Application (2027-2032) & (K Dose)
Table 71. Global Pertussis Booster Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Sanofi Pasteur Basic Information, Pertussis Booster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Pasteur Pertussis Booster Vaccine Product Portfolios and Specifications
Table 74. Sanofi Pasteur Pertussis Booster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 75. Sanofi Pasteur Main Business
Table 76. Sanofi Pasteur Latest Developments
Table 77. GSK Basic Information, Pertussis Booster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. GSK Pertussis Booster Vaccine Product Portfolios and Specifications
Table 79. GSK Pertussis Booster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 80. GSK Main Business
Table 81. GSK Latest Developments
Table 82. Mitsubishi Tanabe Pharma Basic Information, Pertussis Booster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Mitsubishi Tanabe Pharma Pertussis Booster Vaccine Product Portfolios and Specifications
Table 84. Mitsubishi Tanabe Pharma Pertussis Booster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 85. Mitsubishi Tanabe Pharma Main Business
Table 86. Mitsubishi Tanabe Pharma Latest Developments
Table 87. KM Biologics Basic Information, Pertussis Booster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. KM Biologics Pertussis Booster Vaccine Product Portfolios and Specifications
Table 89. KM Biologics Pertussis Booster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 90. KM Biologics Main Business
Table 91. KM Biologics Latest Developments
Table 92. Wuhan Institute of Biological Products Basic Information, Pertussis Booster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Wuhan Institute of Biological Products Pertussis Booster Vaccine Product Portfolios and Specifications
Table 94. Wuhan Institute of Biological Products Pertussis Booster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 95. Wuhan Institute of Biological Products Main Business
Table 96. Wuhan Institute of Biological Products Latest Developments
Table 97. Walvax Biotechnology Basic Information, Pertussis Booster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Walvax Biotechnology Pertussis Booster Vaccine Product Portfolios and Specifications
Table 99. Walvax Biotechnology Pertussis Booster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 100. Walvax Biotechnology Main Business
Table 101. Walvax Biotechnology Latest Developments
Table 102. Chengdu Institute of Biological Products Basic Information, Pertussis Booster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Chengdu Institute of Biological Products Pertussis Booster Vaccine Product Portfolios and Specifications
Table 104. Chengdu Institute of Biological Products Pertussis Booster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 105. Chengdu Institute of Biological Products Main Business
Table 106. Chengdu Institute of Biological Products Latest Developments
Table 107. Minhai Biotechnology Basic Information, Pertussis Booster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Minhai Biotechnology Pertussis Booster Vaccine Product Portfolios and Specifications
Table 109. Minhai Biotechnology Pertussis Booster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 110. Minhai Biotechnology Main Business
Table 111. Minhai Biotechnology Latest Developments
Table 1. Pertussis Booster Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pertussis Booster Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Acellular Vaccines
Table 4. Major Players of Whole-Cell Vaccines
Table 5. Global Pertussis Booster Vaccine Sales by Type (2021-2026) & (K Dose)
Table 6. Global Pertussis Booster Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Pertussis Booster Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Pertussis Booster Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Pertussis Booster Vaccine Sale Price by Type (2021-2026) & (US$/Dose)
Table 10. Global Pertussis Booster Vaccine Sale by Application (2021-2026) & (K Dose)
Table 11. Global Pertussis Booster Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Pertussis Booster Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Pertussis Booster Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Pertussis Booster Vaccine Sale Price by Application (2021-2026) & (US$/Dose)
Table 15. Global Pertussis Booster Vaccine Sales by Company (2021-2026) & (K Dose)
Table 16. Global Pertussis Booster Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Pertussis Booster Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Pertussis Booster Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Pertussis Booster Vaccine Sale Price by Company (2021-2026) & (US$/Dose)
Table 20. Key Manufacturers Pertussis Booster Vaccine Producing Area Distribution and Sales Area
Table 21. Players Pertussis Booster Vaccine Products Offered
Table 22. Pertussis Booster Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Pertussis Booster Vaccine Sales by Geographic Region (2021-2026) & (K Dose)
Table 26. Global Pertussis Booster Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Pertussis Booster Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Pertussis Booster Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Pertussis Booster Vaccine Sales by Country/Region (2021-2026) & (K Dose)
Table 30. Global Pertussis Booster Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Pertussis Booster Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Pertussis Booster Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Pertussis Booster Vaccine Sales by Country (2021-2026) & (K Dose)
Table 34. Americas Pertussis Booster Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Pertussis Booster Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Pertussis Booster Vaccine Sales by Type (2021-2026) & (K Dose)
Table 37. Americas Pertussis Booster Vaccine Sales by Application (2021-2026) & (K Dose)
Table 38. APAC Pertussis Booster Vaccine Sales by Region (2021-2026) & (K Dose)
Table 39. APAC Pertussis Booster Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Pertussis Booster Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Pertussis Booster Vaccine Sales by Type (2021-2026) & (K Dose)
Table 42. APAC Pertussis Booster Vaccine Sales by Application (2021-2026) & (K Dose)
Table 43. Europe Pertussis Booster Vaccine Sales by Country (2021-2026) & (K Dose)
Table 44. Europe Pertussis Booster Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Pertussis Booster Vaccine Sales by Type (2021-2026) & (K Dose)
Table 46. Europe Pertussis Booster Vaccine Sales by Application (2021-2026) & (K Dose)
Table 47. Middle East & Africa Pertussis Booster Vaccine Sales by Country (2021-2026) & (K Dose)
Table 48. Middle East & Africa Pertussis Booster Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Pertussis Booster Vaccine Sales by Type (2021-2026) & (K Dose)
Table 50. Middle East & Africa Pertussis Booster Vaccine Sales by Application (2021-2026) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of Pertussis Booster Vaccine
Table 52. Key Market Challenges & Risks of Pertussis Booster Vaccine
Table 53. Key Industry Trends of Pertussis Booster Vaccine
Table 54. Pertussis Booster Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Pertussis Booster Vaccine Distributors List
Table 57. Pertussis Booster Vaccine Customer List
Table 58. Global Pertussis Booster Vaccine Sales Forecast by Region (2027-2032) & (K Dose)
Table 59. Global Pertussis Booster Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Pertussis Booster Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 61. Americas Pertussis Booster Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Pertussis Booster Vaccine Sales Forecast by Region (2027-2032) & (K Dose)
Table 63. APAC Pertussis Booster Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Pertussis Booster Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 65. Europe Pertussis Booster Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Pertussis Booster Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 67. Middle East & Africa Pertussis Booster Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Pertussis Booster Vaccine Sales Forecast by Type (2027-2032) & (K Dose)
Table 69. Global Pertussis Booster Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Pertussis Booster Vaccine Sales Forecast by Application (2027-2032) & (K Dose)
Table 71. Global Pertussis Booster Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Sanofi Pasteur Basic Information, Pertussis Booster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Pasteur Pertussis Booster Vaccine Product Portfolios and Specifications
Table 74. Sanofi Pasteur Pertussis Booster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 75. Sanofi Pasteur Main Business
Table 76. Sanofi Pasteur Latest Developments
Table 77. GSK Basic Information, Pertussis Booster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. GSK Pertussis Booster Vaccine Product Portfolios and Specifications
Table 79. GSK Pertussis Booster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 80. GSK Main Business
Table 81. GSK Latest Developments
Table 82. Mitsubishi Tanabe Pharma Basic Information, Pertussis Booster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Mitsubishi Tanabe Pharma Pertussis Booster Vaccine Product Portfolios and Specifications
Table 84. Mitsubishi Tanabe Pharma Pertussis Booster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 85. Mitsubishi Tanabe Pharma Main Business
Table 86. Mitsubishi Tanabe Pharma Latest Developments
Table 87. KM Biologics Basic Information, Pertussis Booster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. KM Biologics Pertussis Booster Vaccine Product Portfolios and Specifications
Table 89. KM Biologics Pertussis Booster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 90. KM Biologics Main Business
Table 91. KM Biologics Latest Developments
Table 92. Wuhan Institute of Biological Products Basic Information, Pertussis Booster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Wuhan Institute of Biological Products Pertussis Booster Vaccine Product Portfolios and Specifications
Table 94. Wuhan Institute of Biological Products Pertussis Booster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 95. Wuhan Institute of Biological Products Main Business
Table 96. Wuhan Institute of Biological Products Latest Developments
Table 97. Walvax Biotechnology Basic Information, Pertussis Booster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Walvax Biotechnology Pertussis Booster Vaccine Product Portfolios and Specifications
Table 99. Walvax Biotechnology Pertussis Booster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 100. Walvax Biotechnology Main Business
Table 101. Walvax Biotechnology Latest Developments
Table 102. Chengdu Institute of Biological Products Basic Information, Pertussis Booster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Chengdu Institute of Biological Products Pertussis Booster Vaccine Product Portfolios and Specifications
Table 104. Chengdu Institute of Biological Products Pertussis Booster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 105. Chengdu Institute of Biological Products Main Business
Table 106. Chengdu Institute of Biological Products Latest Developments
Table 107. Minhai Biotechnology Basic Information, Pertussis Booster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Minhai Biotechnology Pertussis Booster Vaccine Product Portfolios and Specifications
Table 109. Minhai Biotechnology Pertussis Booster Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 110. Minhai Biotechnology Main Business
Table 111. Minhai Biotechnology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pertussis Booster Vaccine
Figure 2. Pertussis Booster Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pertussis Booster Vaccine Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Pertussis Booster Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pertussis Booster Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pertussis Booster Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Pertussis Booster Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Acellular Vaccines
Figure 12. Product Picture of Whole-Cell Vaccines
Figure 13. Global Pertussis Booster Vaccine Sales Market Share by Type in 2026
Figure 14. Global Pertussis Booster Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Pertussis Booster Vaccine Consumed in 12 Months Below
Figure 16. Global Pertussis Booster Vaccine Market: 12 Months Below (2021-2026) & (K Dose)
Figure 17. Pertussis Booster Vaccine Consumed in 12 Months Above
Figure 18. Global Pertussis Booster Vaccine Market: 12 Months Above (2021-2026) & (K Dose)
Figure 19. Global Pertussis Booster Vaccine Sale Market Share by Application (2025)
Figure 20. Global Pertussis Booster Vaccine Revenue Market Share by Application in 2026
Figure 21. Pertussis Booster Vaccine Sales by Company in 2026 (K Dose)
Figure 22. Global Pertussis Booster Vaccine Sales Market Share by Company in 2026
Figure 23. Pertussis Booster Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Pertussis Booster Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Pertussis Booster Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Pertussis Booster Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Pertussis Booster Vaccine Sales 2021-2026 (K Dose)
Figure 28. Americas Pertussis Booster Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Pertussis Booster Vaccine Sales 2021-2026 (K Dose)
Figure 30. APAC Pertussis Booster Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Pertussis Booster Vaccine Sales 2021-2026 (K Dose)
Figure 32. Europe Pertussis Booster Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Pertussis Booster Vaccine Sales 2021-2026 (K Dose)
Figure 34. Middle East & Africa Pertussis Booster Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Pertussis Booster Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Pertussis Booster Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Pertussis Booster Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Pertussis Booster Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Pertussis Booster Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Pertussis Booster Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Pertussis Booster Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Pertussis Booster Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Pertussis Booster Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Pertussis Booster Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Pertussis Booster Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Pertussis Booster Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Pertussis Booster Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Pertussis Booster Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Pertussis Booster Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Pertussis Booster Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Pertussis Booster Vaccine
Figure 73. Industry Chain Structure of Pertussis Booster Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Pertussis Booster Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Pertussis Booster Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Pertussis Booster Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Pertussis Booster Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Pertussis Booster Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Pertussis Booster Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Pertussis Booster Vaccine
Figure 2. Pertussis Booster Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pertussis Booster Vaccine Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Pertussis Booster Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pertussis Booster Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pertussis Booster Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Pertussis Booster Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Acellular Vaccines
Figure 12. Product Picture of Whole-Cell Vaccines
Figure 13. Global Pertussis Booster Vaccine Sales Market Share by Type in 2026
Figure 14. Global Pertussis Booster Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Pertussis Booster Vaccine Consumed in 12 Months Below
Figure 16. Global Pertussis Booster Vaccine Market: 12 Months Below (2021-2026) & (K Dose)
Figure 17. Pertussis Booster Vaccine Consumed in 12 Months Above
Figure 18. Global Pertussis Booster Vaccine Market: 12 Months Above (2021-2026) & (K Dose)
Figure 19. Global Pertussis Booster Vaccine Sale Market Share by Application (2025)
Figure 20. Global Pertussis Booster Vaccine Revenue Market Share by Application in 2026
Figure 21. Pertussis Booster Vaccine Sales by Company in 2026 (K Dose)
Figure 22. Global Pertussis Booster Vaccine Sales Market Share by Company in 2026
Figure 23. Pertussis Booster Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Pertussis Booster Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Pertussis Booster Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Pertussis Booster Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Pertussis Booster Vaccine Sales 2021-2026 (K Dose)
Figure 28. Americas Pertussis Booster Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Pertussis Booster Vaccine Sales 2021-2026 (K Dose)
Figure 30. APAC Pertussis Booster Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Pertussis Booster Vaccine Sales 2021-2026 (K Dose)
Figure 32. Europe Pertussis Booster Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Pertussis Booster Vaccine Sales 2021-2026 (K Dose)
Figure 34. Middle East & Africa Pertussis Booster Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Pertussis Booster Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Pertussis Booster Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Pertussis Booster Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Pertussis Booster Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Pertussis Booster Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Pertussis Booster Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Pertussis Booster Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Pertussis Booster Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Pertussis Booster Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Pertussis Booster Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Pertussis Booster Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Pertussis Booster Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Pertussis Booster Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Pertussis Booster Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Pertussis Booster Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Pertussis Booster Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Pertussis Booster Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Pertussis Booster Vaccine
Figure 73. Industry Chain Structure of Pertussis Booster Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Pertussis Booster Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Pertussis Booster Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Pertussis Booster Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Pertussis Booster Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Pertussis Booster Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Pertussis Booster Vaccine Revenue Market Share Forecast by Application (2027-2032)
